On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available during pregnancy, researchers announced.

Their findings come from a multinational study of more than 640 pregnant women with HIV across four continents. The current study compared three antiretroviral drug regimens and found that regimens containing dolutegravir were more effective in suppressing HIV than a commonly used regimen containing efavirenz.